<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" id="no-js"><!-- InstanceBegin template="/Templates/ContentPage_Wide.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease</title>
<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="meta-data" -->
<meta name="Description"    content="" />
<meta name="Keywords"       content="" />
<meta name="Volume" content="63" />
<meta name="Issue" content="04" />
<meta name="Page" content="69" />
<meta name="Month" content="01" />
<meta name="Day" content="31" />
<meta name="Year" content="2014" />
<meta name="Issue_Num" content="4" />
<meta name="MMWR_Type" content="mm" />
<meta name="Date" content="2014-01-31" />
<script language="Javascript" type="text/javascript">
<!--
var img_folder = '../../images/';
var deRef="../../";
var reportTitle = 'Weekly';
var reportDate = 'January 31, 2014 / 63(04);69-72';
//-->
</script>
<script language="javascript1.2" type="text/javascript" src="https://www.cdc.gov/mmwr/scripts/scripts.js"></script>
<script language="javascript1.2" type="text/javascript" src="https://www.cdc.gov/scripts/scripts_reports.js"></script>
<!-- InstanceEndEditable --><!-- InstanceParam name="class" type="text" value="" --><!-- InstanceParam name="localFilesPath" type="text" value="mmwr" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="optionalBreadCrumbs" type="boolean" value="true" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiCarousel" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiDatePicker" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiTabs" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->

<meta http-equiv="content-type" content="text/html; charset=utf-8" />

<meta name="template.version" content="2.7.1.4" />
<!-- @package: TemplatePackage 'B' @version: "2.7.1.4" -->
<style type="text/css" media="screen">empty{color:#000};@import "https://www.cdc.gov/mmwr/local/B/css/designview/designTime.css"/**/;</style>
<link rel="stylesheet" href="../../../TemplatePackage/css/B/reset.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../../TemplatePackage/css/B/newMods.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../../TemplatePackage/css/B/print.css" type="text/css" media="print" />

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie6_fixes.css" />
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->
<!-- /end compliance patch for microsoft browsers --><!-- JS below -->
<script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/socialMedia.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/anchor.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../../TemplatePackage/3.0/js/libs/moment/moment.min.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->

<script type="text/javascript" src="../../../TemplatePackage/js/B/cdc-gridCompatibility.js"></script>

<link rel="shortcut icon" href="../../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
});
</script>
<!--<![endif]-->

<!-- InstanceBeginEditable name="local-css" -->
<link href="https://www.cdc.gov/mmwr/local/B/css/local.css" rel="stylesheet" type="text/css" media="screen" />
<!-- InstanceEndEditable -->
<!-- InstanceBeginEditable name="mmwr-css" -->
<link href="https://www.cdc.gov/mmwr/local/B/css/mmwr2.css" rel="stylesheet" type="text/css" media="screen" />
<!-- InstanceEndEditable -->
</head>
<body id="contentPageWide" class=" widePage v270">

<div id="skipmenu">
	<a href="mm6304a1.htm#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="mm6304a1.htm#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="mm6304a1.htm#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
</div>
<div id="wrapper">
<div id="wrapper-inner">
<div id="branding">
    <span id="homeward"><a href="../../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People." border="0" /><a href="../../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>

    	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
    </div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
</div>

<div id="content">
<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
<h2><a href="../../../mmwr.1.html">Morbidity and Mortality Weekly Report (<i>MMWR</i>)</a></h2>
<!-- InstanceEndEditable -->
    </div>
<div id="content-inner">
        <div class="pageOptions-horizontal">
            <!-- ########## BREADCRUMBS START HERE ########## -->
                <!-- InstanceBeginEditable name="breadcrumbs" -->
                <div id="breadBox">
	<ul id="breadcrumbs">
		<li class="firstChild"><a href="../../../mmwr.1.html"><i>MMWR</i></a></li>
		<!--<li><a href="#">Another Breadcrumb</a></li> -->
	</ul>
	    <p id="return-link">&nbsp;</p>
</div>

                <!-- InstanceEndEditable -->
                <div class="pageOptions-inner">
                    <ul class="forWide">
                        <li class="print"><a href="javascript:window.print();" title="Print page.">&nbsp;</a></li>

                        <!-- InstanceBeginEditable name="local-options" -->
                        <li class="subscribe"><a href="http://service.govdelivery.com/service/subscribe.html?code=USCDC_921" title="Get Email Updates from MMWR">&nbsp;</a></li>
<li class="rss"><a href="../../rss/mmwr.xml" title="Subscribe to MMWR RSS feeds">&nbsp;</a></li>
<li class="podcast"><a href="../../mmwrpodcasts.html" title="Listen to MMWR podcasts">&nbsp;</a></li>
                       <li><a href="https://www.cdc.gov/mmwr/pdf/wk/mm6304.pdf" title="Download PDF">&nbsp;</a></li>
            <!-- InstanceEndEditable -->
        </ul>
  </div>
</div>
<div id="socialMediaContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="mm6304a1.htm#"><span id="share_facebook" class="facebookRecommend"></span></a>
	 	<a class="share_button_twitter" title="Twitter" href="mm6304a1.htm#"><span id="share_twitter" class="twitterTweet"></span></a>
		<a class="share_button noLinking" href="mm6304a1.htm#socialMediaContainer"><img src="../../../TemplatePackage/images/social/sm-plus.gif" alt="Share" /><span class="shareButtonEn">Share</span><span class="shareButtonEs">Compartir</span></a>
	</div>
</div>

<!-- InstanceBeginEditable name="include-contactInfo1" -->
<div class="contactArea"><!--a href="#">For Questions About [insert type/label] Contact Us</a>--></div>
<!-- InstanceEndEditable -->
    <div id="content-main">
        <div class="main-inner">
            <!-- ########## CONTENT STARTS HERE ########## -->
            <!-- InstanceBeginEditable name="content-main" -->
                    <div class="syndicate">
                    <div class="mSyndicate">
<h1>CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease</h1>
<!-- this will dynamically write out the report title and date -->
<script language="Javascript" type="text/javascript">
<!--
   var textOut = "";
   if (reportTitle == "MMWR in Brief")
   {
     
	 textOut += '<h2>' +  '<i>' + "MMWR " + '<\/i>' + "in Brief" + '<\/h2>';
   }
   else
   {
	 textOut += '<i><h2>' +  reportTitle + '<\/h2><\/i>';   
   }
   textOut += '<strong>' + reportDate + '<\/strong><br /><br />';
   document.write(textOut);
// -->
</script>

<p><i>This is another in a series of occasional </i>MMWR<i> reports titled CDC Grand Rounds. These reports are based on grand rounds presentations at CDC on high-profile issues in public health science, practice, and policy. Information about CDC Grand Rounds is available at </i><a href="http://www.cdc.gov/about/grand-rounds">http://www.cdc.gov/about/grand-rounds</a><i>. </i></p>
				<p class="reported-by-text">Eileen F. Dunne, MD<span class="superscript">1</span>, Lauri E. Markowitz, MD<span class="superscript">1</span>, Mona Saraiya, MD<span class="superscript">2</span>, Shannon Stokley, MPH<span class="superscript">3</span>, Amy Middleman, MD<span class="superscript">4</span>, Elizabeth R. Unger, PhD, MD<span class="superscript">5</span>, Alcia Williams, MD<span class="superscript">6</span>, John Iskander, MD<span class="superscript">6</span> (Author affiliations at end of text)</p>
				<p><b>Magnitude of the Problem</b></p>
				<p>Human papillomavirus (HPV) infection is the most common sexually transmitted infection in men and women in the United States. Most sexually active persons will acquire HPV in their lifetime. Recent data indicate that approximately 79 million persons are currently infected with HPV, and 14 million persons are newly infected each year in the United States (<i>1</i>).</p>
				<p>Of the more than 150 different types of HPV, approximately 40 are transmitted through sexual contact and infect the anogenital region and other mucosal sites of the body. Mucosal HPV types are classified as either high-risk HPV (oncogenic) (e.g., types 16 and 18) or low-risk HPV (e.g., types 6 and 11). High-risk HPV causes many cancers of the cervix, vagina, vulva, penis, and anus. HPV16 is linked to many oropharyngeal cancers. Low-risk HPV causes anogenital warts and recurrent respiratory papillomatosis, a rare but important condition in which warts grow in the throat and airway. Most infections cause no symptoms and are not clinically significant, but persistent infection can lead to disease or cancer.</p>
				<p>Recent U.S. population-based studies conducted by CDC show that 66&#37; of cervical cancers, 55&#37; of vaginal cancers, 79&#37; of anal cancers, and 62&#37; of oropharyngeal cancers are attributable to HPV types 16 or 18. Each year in the United States, an estimated 26,000 new cancers are attributable to HPV, about 17,000 in women and 9,000 in men (<i>2</i>).</p>
				<p>Disparities exist in HPV-associated cervical cancer rates by race/ethnicity, with higher incidence rates among Hispanic, black, and American Indian/Alaskan Native women than among whites. HPV-associated vaginal cancers are slightly more frequent among blacks, and vulvar cancers are more frequent among whites. HPV-associated oropharyngeal cancers have been increasing in frequency among both sexes, more among males than females, as well as among most racial/ethnic groups, with the exception of blacks (<i>3</i>). HPV-associated anal cancers have increased among males and females across all racial/ethnic groups (<i>3</i>).</p>
				<p><b>Evidence-Based HPV Prevention</b></p>
				<p>Two HPV vaccines (bivalent and quadrivalent) are licensed by the Food and Drug Administration (FDA). Both vaccines are directed against HPV16 and HPV18, types that cause cervical cancers and other HPV-associated cancers. Quadrivalent vaccine is also directed against HPV6 and HPV11, types that cause anogenital warts. Data from clinical trials show that both vaccines, when given as a 3-dose series, have very high efficacy for prevention of vaccine type&#8211;associated cervical precancers (<i>4&#8211;6</i>) (<span class="callout-pink"><a href="mm6304a1.htm#tab">Table</a></span>). Quadrivalent HPV vaccine has been shown to prevent HPV16- and HPV18-associated vaginal, vulvar, and anal precancers (<i>7,8</i>) and HPV6- and HPV11-associated anogenital warts (<i>9</i>). The vaccines are prophylactic and do not prevent progression of existing infection to disease or treat existing disease (<i>10</i>). No clinical trial data are currently available to demonstrate efficacy for prevention of oropharyngeal or penile cancers. However, because many of these are attributable to HPV16, the HPV vaccine is likely to offer protection against these cancers as well.</p>
				<p>The Advisory Committee on Immunization Practices (ACIP) recommends that girls and boys be routinely vaccinated at age 11 or 12 years; vaccine may be given starting at age 9 years (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm">11</a>&#8211;<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm">13</a></i>). In addition, for those who were not vaccinated when they were younger, all girls/young women through age 26 years (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm">12</a></i>) and all boys/young men through age 21 years should be vaccinated (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm">13</a></i>). ACIP recommends that gay, bisexual, and other men who have sex with men be vaccinated through age 26 years (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm">13</a></i>). ACIP considered data on vaccine efficacy and safety, disease burden attributable to HPV, cost-effectiveness of vaccination, and programmatic issues to develop recommendations.</p>
				<p>The HPV vaccine is covered by most private health insurance and government insurance programs. For uninsured, Medicaid-eligible children of American Indian/Alaska Native descent and underinsured persons aged ≤18 years, the Vaccines for Children Program (VFC) provides federally purchased vaccines recommended by ACIP at no cost to those eligible. Approximately 39&#37; of adolescents aged 13&#8211;17 years are eligible for VFC vaccines; nationally, approximately 44,000 vaccination provider sites are enrolled in the VFC program (<i>14</i>). Most vaccine being used in the United States is quadrivalent HPV vaccine. </p>
				<p><b>Current and Future Challenges for HPV Prevention</b></p>
				<p>Improving vaccination coverage is important to reduce the burden of cancer and disease caused by HPV. National HPV vaccination coverage data reveal a concerning trend among female adolescents aged 13&#8211;17 years. In comparison with other vaccinations recommended for adolescents (e.g., tetanus, diphtheria, and acellular pertussis vaccine [Tdap] and meningococcal conjugate vaccine [MenACWY]), HPV vaccination coverage for adolescent girls has increased slowly and remains far below <i>Healthy People 2020</i> targets; an average increase in HPV vaccination coverage of 6 percentage points was observed each year from 2007 through 2011, but no increase occurred from 2011 to 2012 (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm">15</a></i>). Coverage for adolescent girls with at least 1 dose of HPV vaccine was 53.8&#37;, and coverage with all 3 doses was 33.4&#37; in 2012 (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm">15</a></i>) (<a href="mm6304a1.htm#fig">Figure</a>). Wide variations by state also were observed in 2012, with coverage of 3 doses among adolescent girls ranging from a low of 12.1&#37; in Mississippi to a high of 57.7&#37; in Rhode Island (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm">15</a></i>).</p>
				<p>Strategies to increase adolescent HPV vaccination coverage rates in the United States include reminder/recall systems to increase first dose and series completion rates; standing orders for vaccination; education of patients, parents, and health-care providers; health insurance reforms to reduce out-of-pocket costs for vaccines; and increasing the use of alternative vaccination sites (e.g., schools). School requirements have been found to increase vaccination coverage for Tdap and MenACWY; however, HPV vaccine is required for school entry in only a few jurisdictions. Health-care providers should administer HPV vaccine during visits when Tdap and MenACWY are administered. The single most important predictor of vaccination in the clinical setting is a strong recommendation from a health-care provider (<i>16</i>).</p>
				<p>Monitoring for adverse events after HPV vaccination is occurring through several systems. Two federal systems are the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD). From June 2006 through March 2013, approximately 56 million doses of HPV4 were distributed in the United States. During that period, VAERS received a total of 21,194 reports of adverse events occurring in females after receipt of HPV4; 92.1&#37; of these events were classified as nonserious (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a4.htm">17</a></i>). Among nonserious adverse events, the most commonly reported generalized symptoms were syncope (fainting), dizziness, nausea, headache, fever, and urticaria (hives); the most commonly reported local symptoms were injection-site pain, redness, and swelling (<i><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a4.htm">17</a></i>). Among 600,588 doses of HPV4 administered to females aged 9&#8211;26 years in VSD, no significant increased risk was observed for any of the prespecified adverse events after vaccination, including Guillain-Barré syndrome, seizures, syncope, appendicitis, stroke, venous thromboembolism, or anaphylaxis and other allergic reactions (<i>18</i>).</p>
				<p>Evaluations to assess the impact of HPV vaccine on biologic outcomes (e.g., HPV prevalence in the population, incidence of anogenital warts and HPV-associated precancers/cancers, and HPV type distribution in lesions) are currently underway but are associated with challenges. For example, most HPV-associated disease outcomes are not reported nationally and therefore require new data collection systems. Also, changes in cervical cancer screening recommendations and in terminology used for pathology will impact surveillance for cervical precancers. Moreover, the impact on HPV-associated cancers requires a decade or longer to measure. Data being used to measure biologic impact include those from the National Health and Nutrition Examination Survey (NHANES), sentinel surveillance systems, cancer registries, administrative data such as Marketscan and Medicaid data, and other special evaluations. Ongoing impact monitoring and surveillance of HPV vaccination are important to assess the duration of vaccine-induced protection, the potential replacement of vaccine HPV types with nonvaccine types, and the efficacy of &lt;3 vaccine doses. Despite challenges in measuring vaccination impact, recent NHANES data demonstrate reductions of the prevalence of HPV types 6, 11, 16, and 18 (<i>19</i>), and Marketscan data indicate a reduction of the prevalence of anogenital warts (<i>20</i>).</p>
				<p><b>Conclusion</b></p>
				<p>The burden and cost of HPV-associated disease and cancer remain an important public health problem. Reducing the burden of HPV-associated cancer and disease through vaccination requires an integrated approach that includes clinical medicine, public health, and public policy. Two FDA-licensed prophylactic HPV vaccines are safe, well tolerated, and highly effective. Vaccination is routinely recommended for girls and boys aged 11 or 12 years; however, vaccination coverage is well below <i>Healthy People 2020</i> targets. An important public health goal is enhancing HPV disease prevention by improving vaccination coverage through public policy and clinical practice. Programs are in place to monitor coverage, safety, and postlicensure impact of HPV vaccine in the United States, and these will continue to provide important information on the HPV vaccination program.</p>
				<p class="footnote-w-rule-text-indent-1">	<span class="superscript">1</span>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; <span class="superscript">2</span>National Center for Chronic Disease Prevention and Health Promotion; <span class="superscript">3</span>National Center for Immunization and Respiratory Diseases; <span class="superscript">4</span>University of Oklahoma Health Sciences Center; <span class="superscript">5</span>National Center for Emerging and Zoonotic Infectious Diseases; <span class="superscript">6</span>Office of the Associate Director for Science, CDC (Corresponding author: Eileen F. Dunne, <a href="mailto:dde9@cdc.gov">dde9@cdc.gov</a>, 404-639-6184)</p>
				<h3>References</h3>
				<ol><li>	Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among U.S. women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013;40:187&#8211;93.</li>
				<li>	CDC. Human papillomavirus (HPV)-associated cancers. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at <a href="http://www.cdc.gov/cancer/hpv/statistics/cases.htm">http://www.cdc.gov/cancer/hpv/statistics/cases.htm</a>.</li>
				<li>	Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975&#8211;2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013;105:175&#8211;201.</li>
				<li>	The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915&#8211;27.</li>
				<li>	Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301&#8211;14.</li>
				<li>	Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res 2009;2:868&#8211;78.</li>
				<li>	Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 2007;369:1693&#8211;702.</li>
				<li>	Palefsky J, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365:1576&#8211;85.</li>
				<li>	Future I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010;341:c3493.</li>
				<li>	Hildesheim A, Herrero R, Wacholder S, et al. Effect of human papillomavirus 16/18 L1 virus like particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007;298:743&#8211;53.</li>
				<li><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm">	CDC. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56(No. RR-2).</a></li>
				<li><a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm">	CDC. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR 2010;59:626&#8211;9.</a></li>
				<li>	<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm">CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males&#8212;Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011;60:1705&#8211;8.</a></li>
				<li>	CDC. VFC Program Management Survey data (2010). Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at <a href="http://www2a.cdc.gov/nip/irar/grantee/vfcprovider10.asp">http://www2a.cdc.gov/nip/irar/grantee/vfcprovider10.asp</a>.</li>
				<li>	<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm">CDC. National and state vaccination coverage among adolescents aged 13&#8211;17 years&#8212;United States, 2012. MMWR 2013;62:685&#8211;93.</a></li>
				<li>	Dorell C, Yankey D, Kennedy A, Stokley S. Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: National Immunization Survey&#8211;Teen, 2010. Clin Pediatr (Phila) 2013;52:162&#8211;70.</li>
				<li>	<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6229a4.htm">CDC. Human papillomavirus vaccination coverage among adolescent girls, 2007&#8211;2012, and postlicensure vaccine safety monitoring, 2006&#8211;2013&#8212;United States. MMWR 2013;62:591&#8211;5.</a></li>
				<li>	Gee J, Naleway A, Shui I, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011;29:8279&#8211;84.</li>
				<li>	Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003&#8211;2010. J Infect Dis 2013;208:385&#8211;93.</li>
				<li>	Flagg EW, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003&#8211;2010: potential impact of human papillomavirus vaccination. Am J Pub Health 2013;103:1428&#8211;35.</li></ol>
			<br />
			<div class="table-story">
				<table id="table-1" class="data-table">
					<tbody>
						<tr>
							<th class="header-row" scope="col" colspan="4">
								<p class="title"><b><a name="tab" id="tab"></a>TABLE. Results of selected clinical trials* on human papillomavirus (HPV) vaccine efficacy against HPV vaccine-type precancers and anogenital warts</b></p>
							</th>
						</tr>
						<tr>
							<td scope="row" class="col-head">
								<p class="table-data-8pt-semibold-centered"><b>Outcome</b></p>
							</td>
							<td class="col-head">
								<p class="table-data-8pt-semibold-centered"><b>Vaccine</b></p>
							</td>
							<td class="col-head">
								<p class="table-data-8pt-semibold-centered"><b>Sex</b></p>
							</td>
							<td class="col-head">
								<p class="table-data-8pt-semibold-centered"><b>Vaccine efficacy</b></p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Cervical precancer</p>
							</td>
							<td class="data-row">
								<p class="table-data-indent-1">Bivalent and quadrivalent</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Females</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">&gt;93&#37; </p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Vaginal/Vulvar precancer</p>
							</td>
							<td class="data-row">
								<p class="table-data-indent-1">Quadrivalent</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Females</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">100&#37;</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="data-row">
								<p class="table-data-8pt">Anal precancer</p>
							</td>
							<td class="data-row">
								<p class="table-data-indent-1">Quadrivalent</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">Males</p>
							</td>
							<td class="data-row">
								<p class="table-data-8pt">75&#37;</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="last-row">
								<p class="table-data-8pt">Anogenital warts</p>
							</td>
							<td class="last-row">
								<p class="table-data-indent-1">Quadrivalent</p>
							</td>
							<td class="last-row">
								<p class="table-data-8pt">Females<br/>Males</p>
							</td>
							<td class="last-row">
								<p class="table-data-8pt">99&#37;<br/>89&#37;</p>
							</td>
						</tr>
						<tr>
							<td scope="row" class="footnote-row" colspan="4">
								<p class="x8pt-footnote-supports-indent-1"><b>Sources:</b> Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301&#8211;14. </p>
								<p class="x8pt-footnote-supports-indent-1">Kjaer SK, Sigurdsson K, Iversen OE, et al. A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res 2009;2:868&#8211;78.</p>
								<p class="x8pt-footnote-supports-indent-1">Future I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010;341:c3493.</p>
								<p class="x8pt-footnote-supports-indent-1">Guiliano AR, Palefsky JM, Goldstone S, Moreira ED, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011;364:401&#8211;11.</p>
								<p class="x8pt-footnote-supports-indent-1">Palefsky J, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011;365:1576&#8211;85.</p>
								<p class="x8pt-footnote-supports-indent-1">Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012;13:89&#8211;99.</p>
								<p class="x8pt-footnote-supports-indent-1">*	Population includes the per-protocol and according-to-protocol population. Subjects received all 3 doses, and cases were counted 1 month after dose 3.</p>
							</td>
						</tr>
					</tbody>
				</table>
			</div>
            <br />
			<div class="figure-story">
				<div class="figure-story">
					<p class="title"><b><a name="fig" id="fig"></a>FIGURE. Estimated vaccination coverage with selected vaccines and doses among adolescents aged 13&#8211;17 years, by survey year &#8212; National Immunization Survey&#8211;Teen, United States, 2006&#8211;2012</b></p>
				</div>
				<div class="figure-story">
					<img src="https://www.cdc.gov/mmwr/preview/mmwrhtml/figures/m6304a1f.gif" alt="The figure shows estimated vaccination coverage with selected vaccines and doses among adolescents aged 13-17 years, by survey year, in the United States during 2006-2012. Coverage for adolescent girls with at least 1 dose of human papilloma virus vaccine was 53.8&#37;, and coverage with all 3 doses was 33.4&#37; in 2012."/>
				</div>
                <div class="figure-story">
					<p class="footnote-no-indent"><b>Abbreviations:</b> Tdap = tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis; MenACWY = meningococcal conjugate; HPV = human papillomavirus.</p>
					<p class="footnote-no-indent"><b>Source:</b> CDC. National and state vaccination coverage among adolescents aged 13&#8211;17 years&#8212;United States, 2012. MMWR 2013;62:685&#8211;93. Available at <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm">http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6234a1.htm</a>.</p>
					<p class="x8pt-footnote-supports-indent-1">*	≥1 dose Tdap on or after age 10 years.</p>
					<p class="x8pt-footnote-supports-indent-1"><span class="superscript">&#8224;</span>	≥1 dose MenACWY.</p>
                    <p><b>Alternate Text:</b> The figure above shows estimated vaccination coverage with selected vaccines and doses among adolescents aged 13-17 years, by survey year, in the United States during 2006-2012. Coverage for adolescent girls with at least 1 dose of human papilloma virus vaccine was 53.8&#37;, and coverage with all 3 doses was 33.4&#37; in 2012.
                    </p>
				</div>
			</div>
 </div> <!--mSyndicate div end here-->
</div> <!--Syndicate div end here-->
<br />
<br />
<div style="clear:left; margin:10px; width:98%; border:1px solid black;"><p><small>Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of 
Health and Human Services. <br /><br />References to non-CDC sites on the Internet are 
provided as a service to <i>MMWR</i> readers and do not constitute or imply 
endorsement of these organizations or their programs by CDC or the U.S. 
Department of Health and Human Services. CDC is not responsible for the content 
of pages found at these sites. URL addresses listed in <i>MMWR</i> were current as of 
the date of publication.</small></p></div><br />
<p><small>All <i>MMWR</i> HTML versions of articles are electronic conversions from typeset documents. 
This conversion might result in character translation or format errors in the HTML version. 
Users are referred to the electronic PDF version (<a href="../../../mmwr.1.html">http://www.cdc.gov/mmwr</a>) 
and/or the original <i>MMWR</i> paper copy for printable versions of official text, figures, and tables. 
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. 
Government Printing Office (GPO), Washington, DC 20402-9371; 
telephone: (202) 512-1800. Contact GPO for current prices.</small><br /> 
<br />**Questions or messages regarding errors in formatting should be addressed to 
<a href="javascript:sendIt();">mmwrq@cdc.gov</a>.</p>
<!-- InstanceEndEditable -->
                <!-- /end .main-inner --></div>
                <div id="linkPolicy">&nbsp;</div>
            <!-- /end #content-main--></div>
        <!-- /end #content-inner --></div>
<!-- ########## LEFT NAVIGATION STARTS HERE ########## --><!-- This will not display (render off-screen) in the web browser with CSS enabled except for .applicationNav-->
           <div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
              <div id="nav">
  <h3><a href="../../../mmwr.1.html"><i>MMWR</i> Home</a></h3>
  <ul id="nav-primary">
  
  	 <!-- Dispatch -->
     <!-- li><a href="/mmwr/mmwr_dispatch.html"><i>MMWR</i> Dispatch</a></li -->
 
     <!-- Early Release -->
     <!--li><a href="/mmwr/early_release.html"><i>MMWR</i> Early Release</a></li -->
     <li><a href="https://www.cdc.gov/mmwr/publications/index.html" title="Click for more menu options">Publications</a>
         <ul style="Display:block">
           <li><a href="https://www.cdc.gov/mmwr/index2015.html" title="Click for more menu options">Weekly Report</a>
            <ul>
        	  <li><a href="https://www.cdc.gov/mmwr/mmwr_wk/wk_pvol.html">Past Volumes (1982-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/indrr_2015.html" title="Click for more menu options">Recommendations and Reports</a>
            <ul>
         	  <li><a href="https://www.cdc.gov/mmwr/mmwr_rr/rr_pvol.html">Past Volumes (1990-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/indss_2015.html" title="Click for more menu options">Surveillance Summaries</a>
            <ul>
         	  <li><a href="https://www.cdc.gov/mmwr/mmwr_ss/ss_pvol.html">Past Volumes (1983-2014)</a></li>
            </ul>
           </li>
           <li><a href="https://www.cdc.gov/mmwr/mmwr_su/index.html">Supplements</a></li>
           <li><a href="https://www.cdc.gov/mmwr/mmwr_nd/index.html">Notifiable Diseases</a></li>
         </ul>  
     </li>
     <!-- li><a href="/mmwr/mmwrsrch.htm"><i>MMWR</i> Advanced Search</a></li -->
     <li><a href="https://www.cdc.gov/mmwr/about.html">About <i>MMWR</i></a></li>
     <li><a href="https://www.cdc.gov/mmwr/Contributors/index.html" title="Click for more menu options">Instructions for Authors</a>
            <ul>
         	  <!-- li><a href="/mmwr/Policy.html">Contributor Attribution Policy</a></li -->
        	  <li><a href="https://www.cdc.gov/mmwr/author_guide_rrss.html">Serial Publications</a></li>
              <li><a href="https://www.cdc.gov/mmwr/author_guide.html">Weekly</a></li>
              <li><a href="https://www.cdc.gov/mmwr/author_guide_ce.html">Continuing Education</a></li>
            </ul>
     </li>
     <li><a href="https://www.cdc.gov/mmwr/cme/conted_info.html" title="Click for more menu options">Continuing Education</a>
         <ul style="Display:block">
           <li><a href="https://www.cdc.gov/mmwr/cme/weekly_conted.html">Weekly Publications</a></li>
           <li><a href="https://www.cdc.gov/mmwr/cme/serial_conted.html">Serial Publications</a></li>
		</ul>
	 </li>
	 <li><a href="https://www.cdc.gov/mmwr/StateHealth/index.html">State Health Statistics</a></li>
     <li><a href="https://www.cdc.gov/mmwr/editorial_board.html"><em>MMWR</em> Editorial Board</a></li>
     <li><a href="https://www.cdc.gov/mmwr/staff/staff.html"><i>MMWR</i> Staff</a></li>
  </ul>
</div>
               <!-- InstanceEndEditable -->
           </div>
       <!-- /end #content --></div>

        <div class="preFoot">
<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../../Other/plugins/index.html#pdf"><img src="../../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../../Other/plugins/index.html#doc"><img src="../../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../../Other/plugins/index.html#xls"><img src="../../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../../Other/plugins/index.html#ppt"><img src="../../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../../Other/plugins/index.html#wmv"><img src="../../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../../Other/plugins/index.html#zip"><img src="../../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../../Other/plugins/index.html#ram"><img src="../../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../../Other/plugins/index.html#qt"><img src="../../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
           <div class="pageOptions-horizontal">
               <div class="pageOptions-inner2">
                   <ul class="services">
                       <li class="print"><a href="javascript:window.print();">Print</a></li>
<!-- InstanceBeginEditable name="local-options-horizontal" -->
                       <li class="subscribe"><a href="../../../emailupdates/index.html">Updates</a></li>
                       <li class="rss"><a href="../../rss/mmwr.xml" title="Subscribe to MMWR RSS feeds">Subscribe</a></li>
                       <li class="podcast"><a href="../../mmwrpodcasts.html" title="Listen to MMWR podcasts">Listen</a></li>
                       <li><a href="https://www.cdc.gov/mmwr/pdf/wk/mm6304.pdf" title="Download PDF">Download</a></li>
                        <!-- InstanceEndEditable -->
                    </ul>
                </div>
            </div>
            <!-- InstanceBeginEditable name="include-contactInfo2" -->
            <div class="contactArea"><!--a href="#">For Questions About [insert type/label] Contact Us</a>--></div>
            <!-- InstanceEndEditable -->
            <div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
                <ul>
                <li class="last-reviewed">Page last reviewed: <span>January 31, 2014</span></li>
                <li class="last-updated">Page last updated: <span>January 31, 2014</span></li>
                <li class="content-source">Content source: <a href="../../../index.html">Centers for Disease Control and Prevention</a></li>
                </ul>
                <!-- InstanceEndEditable -->
            </div>

        </div>
        <div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../../index.html">Home</a></li>
			<li><a href="../../../az/a.html">A-Z Index</a></li>
			<li><a href="../../../Other/policies.html">Policies</a></li>
			<li><a href="../../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
        <div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../../az/a.html">A</a></li>
		<li><a href="../../../az/b.html">B</a></li>
		<li><a href="../../../az/c.html">C</a></li>
		<li><a href="../../../az/d.html">D</a></li>
		<li><a href="../../../az/e.html">E</a></li>
		<li><a href="../../../az/f.html">F</a></li>
		<li><a href="../../../az/g.html">G</a></li>
		<li><a href="../../../az/h.html">H</a></li>
		<li><a href="../../../az/i.html">I</a></li>
		<li><a href="../../../az/j.html">J</a></li>
		<li><a href="../../../az/k.html">K</a></li>
		<li><a href="../../../az/l.html">L</a></li>
		<li><a href="../../../az/m.html">M</a></li>
		<li><a href="../../../az/n.html">N</a></li>
		<li><a href="../../../az/o.html">O</a></li>
		<li><a href="../../../az/p.html">P</a></li>
		<li><a href="../../../az/q.html">Q</a></li>
		<li><a href="../../../az/r.html">R</a></li>
		<li><a href="../../../az/s.html">S</a></li>
		<li><a href="../../../az/t.html">T</a></li>
		<li><a href="../../../az/u.html">U</a></li>
		<li><a href="../../../az/v.html">V</a></li>
		<li><a href="../../../az/w.html">W</a></li>
		<li><a href="../../../az/x.html">X</a></li>
		<li><a href="../../../az/y.html">Y</a></li>
		<li><a href="../../../az/z.html">Z</a></li>
		<li><a href="../../../az/0.html">#</a></li>
	</ol>
</div>

    <!-- /end #wrapper-inner --></div>
<!-- /end #wrapper --></div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="MMWR";

<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->


</body>
<!-- InstanceEnd --></html>

